Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorLouisiana State University Health Sciences Center in New Orleans

About this trial

This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

African American

20+ pack years of smoking

eligible for or received LDCT screening

current smoker

Disqualifiers

N/A

Trial design

Design model

Sequential

Treatments tested in this trial

  • Smoking cessation multilevel Intervention

    Behavioral

    The intervention will utilize a multilevel intervention based on the Social Ecological Model's individual, institutional, and community levels.

Treatment groups

250 Participants
are divided into 2 treatment groups
Group A: ControlNo intervention 0 interventions
Group B: ScreeningExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Stage of Change for Smoking Cessation

Stage of change in smoking cessation behavior

Time frame
Baseline, immediately post-intervention, and 6-month follow-up
2

7-Day Point Prevalence Abstinence Rate

Proportion of participants reporting no smoking in the past 7 days

Time frame
Baseline, immediately post-intervention, and 6-month follow-up
3

24-Hour Point Prevalence Abstinence Rate

Proportion of participants reporting no smoking in the past 24 hours

Time frame
Baseline, immediately post-intervention, and 6-month follow-up
4

Daily Cigarette Consumption

Number of cigarettes smoked per day

Time frame
Baseline, immediately post-intervention, and 6-month follow-up

Secondary outcomes

1

Lung Cancer Screening (LDCT) Uptake

Completion of low-dose computed tomography (LDCT) lung cancer screening, assessed using a validated questionnaire.

Time frame
Baseline, immediately post-intervention, 6 months
2

Intent to Undergo Lung Cancer Screening

Participant-reported intention to obtain lung cancer screening, assessed using a previously validated questionnaire.

Time frame
Baseline, immediately post-intervention, 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Louisiana State University Health Sciences Center in New Orleans

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator